Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and envelopes on contact lenses are the primary targets for disinfection systems designed to prevent ocular infections. These structures provide essential protection and structural integrity to bacteria, fungi, and protozoa that may contaminate contact lenses during wear or handling (Stapleton et al., 2013). The accumulation of these microorganisms can lead to the formation of biofilms, which are highly resistant to standard cleaning and are a major risk factor for microbial keratitis (Willmott et al., 2022). Disinfecting agents in multipurpose solutions, such as biguanides and quaternary ammonium compounds, specifically interact with the lipid and protein components of these membranes to induce lysis (Codling et al., 2003). Oxidative systems like hydrogen peroxide provide a broader attack by generating free radicals that disrupt the chemical bonds within the cell envelope (Elder et al., 1993). Maintaining the sterility of the contact lens surface by targeting these envelopes is a fundamental aspect of ocular health for contact lens users. Effective targeting ensures that pathogens are neutralized before they can adhere to the corneal epithelium and initiate an infectious process.
Antimicrobial agents target the microbial cell membranes and envelopes through various mechanisms, primarily involving electrostatic attraction to negatively charged components of the membrane (Codling et al., 2003). This interaction leads to the displacement of stabilizing ions like calcium and magnesium, causing membrane reorganization, increased permeability, and the leakage of essential intracellular components such as potassium ions and proteins (Willmott et al., 2022). Oxidative agents like hydrogen peroxide cause non-specific damage to membrane lipids and proteins through the generation of hydroxyl free radicals, ultimately resulting in cell lysis and death (Elder et al., 1993).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and envelopes.